Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-20 Option Award |
2022-05-24 5:12 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
6,026 | $0.6813 | 65,767 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:30 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
140,250 | $0 | 140,250 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 6:53 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
2,017 | $2.01 | 59,741 (Direct) |
View |
| 2021-11-03 Exercise |
2021-11-03 7:30 pm |
2020-04-11 2026-05-12 |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
7,500 | $1.68 | 148,306 (Direct) |
View |
| 2021-08-03 Exercise(A) |
2021-09-03 4:41 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
7,500 | $1.68 | 148,306 (Direct) |
View |
| 2021-08-03 Exercise(A) |
2021-09-03 4:41 pm |
2020-04-11 2026-05-12 |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
7,500 | $0 | 148,306 (Direct) |
View |
| 2021-08-03 Option Award |
2021-08-04 6:58 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
7,500 | $1.68 | 50,224 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 6:11 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
1,419 | $2.8 | 42,724 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:48 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
76,500 | $0 | 76,500 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:43 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
1,305 | $3 | 41,305 (Direct) |
View |
| 2020-08-14 Exercise |
2020-08-17 8:15 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
5,000 | $1.69 | 145,582 (Direct) |
View |
| 2020-08-14 Exercise |
2020-08-17 8:15 pm |
N/A 2026-05-12 |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
5,000 | $0 | 145,582 (Direct) |
View |